{"id":"NCT01682720","sponsor":"Gilead Sciences","briefTitle":"Sofosbuvir and Ribavirin in Treatment-Naive and Treatment-Experienced Subjects With Chronic Genotype 2 or 3 HCV Infection","officialTitle":"A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of GS-7977+Ribavirin for 12 Weeks in Treatment Naive and Treatment Experienced Subjects With Chronic Genotype 2 or 3 HCV Infection.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-09","primaryCompletion":"2013-10","completion":"2014-01","firstPosted":"2012-09-11","resultsPosted":"2014-10-09","lastUpdate":"2014-10-09"},"enrollment":421,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Hepatitis C"],"interventions":[{"type":"DRUG","name":"SOF","otherNames":["SovaldiÂ®","GS-7977","PSI-7977"]},{"type":"DRUG","name":"RBV","otherNames":[]},{"type":"DRUG","name":"Placebo to match SOF","otherNames":[]},{"type":"DRUG","name":"Placebo to match RBV","otherNames":[]}],"arms":[{"label":"Placebo 12 Weeks (GT2/3)","type":"PLACEBO_COMPARATOR"},{"label":"SOF 12 Weeks (GT2/3)","type":"EXPERIMENTAL"},{"label":"SOF 24 Weeks (GT3)","type":"EXPERIMENTAL"}],"summary":"This study will evaluate the safety, tolerability, and antiviral efficacy of GS-7977 with ribavirin (RBV) in participants with genotype 2 or 3 hepatitis C virus (HCV) infection.","primaryOutcome":{"measure":"Percentage of Participants With Sustained Virologic Response 12 Weeks After Discontinuation of Therapy (SVR12)","timeFrame":"Posttreatment Week 12","effectByArm":[{"arm":"SOF 12 Weeks (GT2)","deltaMin":93.2,"sd":null},{"arm":"SOF 12 Weeks (GT3)","deltaMin":27.3,"sd":null},{"arm":"SOF 24 Weeks (GT3)","deltaMin":85.2,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":7},"locations":{"siteCount":77,"countries":["Austria","Estonia","France","Germany","Italy","Netherlands","Poland","Spain","Sweden","United Kingdom"]},"refs":{"pmids":["24795201","25583164"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":85},"commonTop":["Headache","Fatigue","Pruritus","Asthenia","Nausea"]}}